butyric acid has been researched along with Colitis in 37 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the beneficial effect of the combination of butyrate, Lactobacillus casei, and L-carnitine in a rat colitis model." | 7.80 | Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis. ( Abdolghaffari, AH; Abdollahi, M; Baeeri, M; Ghasemi-Niri, SF; Moeinian, M; Mozaffari, S; Navaea-Nigjeh, M, 2014) |
| "Rats with induced colitis were treated with sodium butyrate, mesalamine, sodium butyrate plus mesalamine, or saline enemas." | 7.69 | Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity. ( Cosenza, V; D'Argenio, G; D'Armiento, FP; De Ritis, F; Delle Cave, M; Gatto, A; Mazzacca, G; Sorrentini, I, 1994) |
| "Treatment with carnitine-loaded liposomes corrected the butyrate metabolic alterations in vitro and reduced the severity of colitis in vivo." | 5.33 | Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes. ( Calvani, M; Calvani, R; Caporaso, N; Casamassimi, A; Ciccodicola, A; D'Argenio, G; Margarucci, S; Peluso, G; Peluso, I; Petillo, O; Rienzo, M, 2006) |
| " The present study is aimed at testing the hypothesis that resistant maltodextrin (RM), a soluble dietary fiber produced by starch debranching, alleviated dextran sulfate sodium- (DSS-) induced colitis in mice." | 3.96 | Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels. ( Han, D; Huang, S; Pang, J; Wang, J; Wang, S; Wu, Y; Wu, Z; Zhang, S, 2020) |
| "To investigate the beneficial effect of the combination of butyrate, Lactobacillus casei, and L-carnitine in a rat colitis model." | 3.80 | Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis. ( Abdolghaffari, AH; Abdollahi, M; Baeeri, M; Ghasemi-Niri, SF; Moeinian, M; Mozaffari, S; Navaea-Nigjeh, M, 2014) |
| " The aim of the present study was to elucidate the probable mechanisms involved in the beneficial effects of a fiber-supplemented diet (5% Plantago ovata seeds) in the trinitrobenzenesulfonic acid (TNBS) model of rat colitis, with special attention to its effects on the production of some of the mediators involved in the inflammatory response, such as tumor necrosis factor alpha (TNFalpha) and nitric oxide (NO)." | 3.71 | Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. ( Azzouz, S; Camuesco, D; Concha, A; Gálvez, J; Lorente, MD; Osuna, A; Redondo, L; Rodríguez-Cabezas, ME; Zarzuelo, A, 2002) |
| "Rats with induced colitis were treated with sodium butyrate, mesalamine, sodium butyrate plus mesalamine, or saline enemas." | 3.69 | Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity. ( Cosenza, V; D'Argenio, G; D'Armiento, FP; De Ritis, F; Delle Cave, M; Gatto, A; Mazzacca, G; Sorrentini, I, 1994) |
| "Colitis was induced by drinking 2% DSS for 7 days." | 1.72 | Intermittent Fasting Alleviates Risk Markers in a Murine Model of Ulcerative Colitis by Modulating the Gut Microbiome and Metabolome. ( Bian, X; Li, L; Li, Y; Man, D; Shi, D; Wang, K; Wang, Q; Wang, S; Wu, J; Wu, W; Yang, L, 2022) |
| "Butyric acid is a short-chain fatty acid (SCFA) produced by the fermentation of carbohydrates, such as dietary fibre in the large bowel." | 1.72 | Physiological activity of E. coli engineered to produce butyric acid. ( Choi, J; Choi, SI; Ham, J; Kim, N; Kim, T; Kim, YR; Lee, HS; Park, YT; Seok, YJ; Yeon, YJ, 2022) |
| "Treatment with carnitine-loaded liposomes corrected the butyrate metabolic alterations in vitro and reduced the severity of colitis in vivo." | 1.33 | Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes. ( Calvani, M; Calvani, R; Caporaso, N; Casamassimi, A; Ciccodicola, A; D'Argenio, G; Margarucci, S; Peluso, G; Peluso, I; Petillo, O; Rienzo, M, 2006) |
| "Colitic oedema was measured as percentage (%) tissue water compared with that in saline controls." | 1.28 | Short chain fatty acid-induced colitis in mice. ( McCafferty, DM; Zeitlin, IJ, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.70) | 18.7374 |
| 1990's | 7 (18.92) | 18.2507 |
| 2000's | 3 (8.11) | 29.6817 |
| 2010's | 10 (27.03) | 24.3611 |
| 2020's | 16 (43.24) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, M | 1 |
| Wu, X | 3 |
| Duan, X | 1 |
| Xu, J | 1 |
| Yang, X | 1 |
| Sheng, X | 1 |
| Lou, P | 1 |
| Shao, C | 1 |
| Lv, C | 1 |
| Yu, Z | 1 |
| Mu, Y | 1 |
| Kinashi, Y | 1 |
| Li, J | 1 |
| Yoshikawa, T | 1 |
| Kishimura, A | 1 |
| Tanaka, M | 1 |
| Matsui, T | 1 |
| Mori, T | 1 |
| Hase, K | 1 |
| Katayama, Y | 1 |
| Chen, MJ | 1 |
| Feng, Y | 1 |
| Gao, L | 1 |
| Lin, MX | 1 |
| Wang, SD | 1 |
| Tong, ZQ | 1 |
| Xia, X | 2 |
| Lin, H | 2 |
| Luo, F | 2 |
| Zhu, L | 2 |
| Chen, S | 2 |
| Luo, H | 2 |
| Ye, F | 2 |
| Peng, X | 2 |
| Zhang, Y | 2 |
| Yang, G | 2 |
| Lin, Q | 2 |
| Wu, J | 1 |
| Man, D | 1 |
| Shi, D | 1 |
| Wu, W | 1 |
| Wang, S | 2 |
| Wang, K | 1 |
| Li, Y | 1 |
| Yang, L | 1 |
| Bian, X | 1 |
| Wang, Q | 2 |
| Li, L | 1 |
| Hu, S | 1 |
| Lin, Z | 1 |
| Zhao, S | 1 |
| Zhang, B | 1 |
| Luo, L | 1 |
| Zeng, L | 1 |
| Chen, Z | 1 |
| Nong, Y | 1 |
| Feng, L | 1 |
| He, Y | 1 |
| Guo, B | 2 |
| Qin, Y | 2 |
| Zhong, X | 1 |
| Qin, J | 1 |
| Wei, J | 1 |
| Dong, M | 1 |
| Pan, S | 1 |
| Su, Z | 1 |
| Bian, Z | 1 |
| Zhang, Q | 2 |
| Sun, X | 1 |
| Liu, L | 1 |
| Liu, H | 1 |
| Mao, L | 1 |
| Yan, Y | 1 |
| Liao, W | 1 |
| Zha, L | 1 |
| Sun, S | 1 |
| Ikeda, Y | 1 |
| Matsuda, S | 1 |
| Caetano, MAF | 1 |
| Magalhães, HIR | 1 |
| Duarte, JRL | 1 |
| Conceição, LB | 1 |
| Castelucci, P | 1 |
| Busbee, PB | 1 |
| Menzel, L | 1 |
| Alrafas, HR | 1 |
| Dopkins, N | 1 |
| Becker, W | 1 |
| Miranda, K | 1 |
| Tang, C | 1 |
| Chatterjee, S | 1 |
| Singh, U | 1 |
| Nagarkatti, M | 1 |
| Nagarkatti, PS | 1 |
| Zhang, S | 1 |
| Huang, S | 1 |
| Wu, Z | 1 |
| Pang, J | 1 |
| Wu, Y | 3 |
| Wang, J | 2 |
| Han, D | 1 |
| Sitkin, S | 1 |
| Vakhitov, T | 1 |
| Pokrotnieks, J | 1 |
| Facchin, S | 1 |
| Buda, A | 1 |
| Savarino, E | 1 |
| Park, YT | 1 |
| Kim, T | 1 |
| Ham, J | 1 |
| Choi, J | 1 |
| Lee, HS | 1 |
| Yeon, YJ | 1 |
| Choi, SI | 1 |
| Kim, N | 1 |
| Kim, YR | 1 |
| Seok, YJ | 1 |
| Zhou, Q | 1 |
| Gu, R | 1 |
| Xue, B | 1 |
| Li, P | 1 |
| Gu, Q | 1 |
| Tortora, K | 1 |
| Femia, AP | 2 |
| Romagnoli, A | 1 |
| Sineo, I | 1 |
| Khatib, M | 1 |
| Mulinacci, N | 1 |
| Giovannelli, L | 1 |
| Caderni, G | 1 |
| Mishiro, T | 1 |
| Kusunoki, R | 1 |
| Otani, A | 1 |
| Ansary, MM | 1 |
| Tongu, M | 1 |
| Harashima, N | 1 |
| Yamada, T | 1 |
| Sato, S | 1 |
| Amano, Y | 1 |
| Itoh, K | 1 |
| Ishihara, S | 1 |
| Kinoshita, Y | 1 |
| Dostal, A | 1 |
| Lacroix, C | 1 |
| Pham, VT | 1 |
| Zimmermann, MB | 1 |
| Del'homme, C | 1 |
| Bernalier-Donadille, A | 1 |
| Chassard, C | 1 |
| Moeinian, M | 1 |
| Ghasemi-Niri, SF | 1 |
| Mozaffari, S | 1 |
| Abdolghaffari, AH | 1 |
| Baeeri, M | 1 |
| Navaea-Nigjeh, M | 1 |
| Abdollahi, M | 1 |
| Gurav, A | 1 |
| Sivaprakasam, S | 1 |
| Bhutia, YD | 1 |
| Boettger, T | 1 |
| Singh, N | 1 |
| Ganapathy, V | 1 |
| Rajendran, VM | 1 |
| Nanda Kumar, NS | 1 |
| Tse, CM | 1 |
| Binder, HJ | 1 |
| Luceri, C | 1 |
| Fazi, M | 1 |
| Di Martino, C | 1 |
| Zolfanelli, F | 1 |
| Dolara, P | 1 |
| Tonelli, F | 1 |
| Xiong, H | 1 |
| Gan, Z | 1 |
| Song, D | 1 |
| Lu, Z | 1 |
| Yi, H | 1 |
| Wang, Y | 1 |
| Du, H | 1 |
| Wu, G | 1 |
| Long, W | 1 |
| Xue, Z | 1 |
| Wang, L | 1 |
| Zhang, X | 1 |
| Pang, X | 1 |
| Zhao, Y | 1 |
| Zhao, L | 1 |
| Zhang, C | 1 |
| Tjellström, B | 1 |
| Högberg, L | 1 |
| Stenhammar, L | 1 |
| Magnusson, KE | 1 |
| Midtvedt, T | 1 |
| Norin, E | 1 |
| Sundqvist, T | 1 |
| Ariake, K | 1 |
| Ohkusa, T | 1 |
| Sakurazawa, T | 1 |
| Kumagai, J | 1 |
| Eishi, Y | 1 |
| Hoshi, S | 1 |
| Yajima, T | 1 |
| Rodríguez-Cabezas, ME | 1 |
| Gálvez, J | 1 |
| Lorente, MD | 1 |
| Concha, A | 1 |
| Camuesco, D | 1 |
| Azzouz, S | 1 |
| Osuna, A | 1 |
| Redondo, L | 1 |
| Zarzuelo, A | 1 |
| D'Argenio, G | 3 |
| Calvani, M | 1 |
| Casamassimi, A | 1 |
| Petillo, O | 1 |
| Margarucci, S | 1 |
| Rienzo, M | 1 |
| Peluso, I | 1 |
| Calvani, R | 1 |
| Ciccodicola, A | 1 |
| Caporaso, N | 1 |
| Peluso, G | 1 |
| Cosenza, V | 2 |
| Sorrentini, I | 1 |
| De Ritis, F | 1 |
| Gatto, A | 1 |
| Delle Cave, M | 2 |
| D'Armiento, FP | 1 |
| Mazzacca, G | 2 |
| Iovino, P | 1 |
| Delle Valle, N | 1 |
| Lombardi, G | 1 |
| Scheppach, W | 1 |
| Christl, SU | 1 |
| Bartram, HP | 1 |
| Richter, F | 1 |
| Kasper, H | 1 |
| von Engelhardt, W | 1 |
| Bartels, J | 1 |
| Kirschberger, S | 1 |
| Meyer zu Düttingdorf, HD | 1 |
| Busche, R | 1 |
| McCafferty, DM | 2 |
| Zeitlin, IJ | 2 |
| Roediger, WE | 1 |
| Latella, G | 1 |
| Caprilli, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prebiotic GOS and Lactoferrin for Beneficial Gut Microbiota With Iron Supplements[NCT03866837] | 288 participants (Actual) | Interventional | 2020-01-15 | Active, not recruiting | |||
| Washed Microbiota Transplantation Combining Exclusive Enteral Nutrition Contribute to Nutritional Improvement of Patients With Crohns' Disease[NCT02897661] | 30 participants (Anticipated) | Interventional | 2016-08-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for butyric acid and Colitis
| Article | Year |
|---|---|
Effects of short-chain fatty acids on the inflamed colonic mucosa.
Topics: Administration, Topical; Animals; Butyrates; Butyric Acid; Colitis; Enema; Fatty Acids, Volatile; Hu | 1997 |
Role of short-chain fatty acids in the hind gut.
Topics: Animals; Apoptosis; Butyrates; Butyric Acid; Cell Division; Colitis; Colon; Colorectal Neoplasms; Di | 1998 |
Metabolism of large bowel mucosa in health and disease.
Topics: Anaerobiosis; Butyrates; Butyric Acid; Colitis; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Di | 1991 |
1 trial available for butyric acid and Colitis
| Article | Year |
|---|---|
Effect of butyrate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: A randomized trial.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Atrophy; Butyric Acid; Colitis; Colon; Colonoscop | 2016 |
33 other studies available for butyric acid and Colitis
| Article | Year |
|---|---|
Topics: Animals; Anti-Inflammatory Agents; Butyrates; Butyric Acid; Colitis; Dextran Sulfate; Female; Gene E | 2021 |
Polyvinyl Butyrate Nanoparticles as Butyrate Donors for Colitis Treatment.
Topics: Animals; Biocompatible Materials; Butyric Acid; Cells, Cultured; Colitis; Dextran Sulfate; Disease M | 2021 |
Composite Sophora Colon-Soluble Capsule Ameliorates DSS-Induced Ulcerative Colitis in Mice via Gut Microbiota-Derived Butyric Acid and NCR
Topics: Animals; Butyric Acid; Colitis; Colitis, Ulcerative; Colon; Disease Models, Animal; Gastrointestinal | 2023 |
Oryzanol Ameliorates DSS-Stimulated Gut Barrier Damage via Targeting the Gut Microbiota Accompanied by the TLR4/NF-κB/NLRP3 Cascade Response In Vivo.
Topics: Animals; Butyric Acid; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Mic | 2022 |
Oryzanol Ameliorates DSS-Stimulated Gut Barrier Damage via Targeting the Gut Microbiota Accompanied by the TLR4/NF-κB/NLRP3 Cascade Response In Vivo.
Topics: Animals; Butyric Acid; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Mic | 2022 |
Oryzanol Ameliorates DSS-Stimulated Gut Barrier Damage via Targeting the Gut Microbiota Accompanied by the TLR4/NF-κB/NLRP3 Cascade Response In Vivo.
Topics: Animals; Butyric Acid; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Mic | 2022 |
Oryzanol Ameliorates DSS-Stimulated Gut Barrier Damage via Targeting the Gut Microbiota Accompanied by the TLR4/NF-κB/NLRP3 Cascade Response In Vivo.
Topics: Animals; Butyric Acid; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Mic | 2022 |
Intermittent Fasting Alleviates Risk Markers in a Murine Model of Ulcerative Colitis by Modulating the Gut Microbiome and Metabolome.
Topics: Akkermansia; Animals; Bile Acids and Salts; Butyric Acid; Chromatography, Liquid; Colitis; Colitis, | 2022 |
Pu-erh tea alleviated colitis-mediated brain dysfunction by promoting butyric acid production.
Topics: Brain; Butyric Acid; Colitis; Humans; Neurotransmitter Agents; Phosphatidylinositol 3-Kinases; Tea | 2023 |
Preventive effect of tilapia skin collagen hydrolysates on ulcerative colitis mice based on metabonomic and 16 S rRNA gene sequencing.
Topics: Acetic Acid; Actinobacteria; Animals; Bacteroidetes; Butyric Acid; Colitis; Colitis, Ulcerative; Col | 2023 |
Sodium Butyrate Inhibits Oxidative Stress and NF-κB/NLRP3 Activation in Dextran Sulfate Sodium Salt-Induced Colitis in Mice with Involvement of the Nrf2 Signaling Pathway and Mitophagy.
Topics: Animals; Butyric Acid; Colitis; Colitis, Ulcerative; Cyclooxygenase 2; Dextran Sulfate; Disease Mode | 2023 |
Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis.
Topics: Animals; Butyric Acid; Carrageenan; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, A | 2023 |
Butyrate Protects Myenteric Neurons Loss in Mice Following Experimental Ulcerative Colitis.
Topics: Animals; Butyric Acid; Colitis; Colitis, Ulcerative; Mice; Mice, Inbred C57BL; Neurons | 2023 |
Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner.
Topics: Animals; Butyric Acid; Colitis; Colon; Disease Models, Animal; Dysbiosis; Female; Gastrointestinal M | 2020 |
Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels.
Topics: Animals; Butyric Acid; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Feces; Fe | 2020 |
Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes.
Topics: Butyrates; Butyric Acid; Colitis; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; | 2021 |
Reply Letter to "Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes".
Topics: Butyric Acid; Colitis; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Microbiota | 2021 |
Physiological activity of E. coli engineered to produce butyric acid.
Topics: Animals; Anti-Inflammatory Agents; Butyric Acid; Carbon; Colitis; Escherichia coli; Glucose; Mice | 2022 |
Phenyl lactic acid alleviates
Topics: Animals; Anti-Inflammatory Agents; Butyric Acid; Colitis; Colon; Cytokines; Dysbiosis; Female; Gastr | 2021 |
Pomegranate By-Products in Colorectal Cancer Chemoprevention: Effects in Apc-Mutated Pirc Rats and Mechanistic Studies In Vitro and Ex Vivo.
Topics: Adenoma; Adenomatous Polyposis Coli Protein; Animals; Anticarcinogenic Agents; Apoptosis; Butyric Ac | 2018 |
Butyric acid attenuates intestinal inflammation in murine DSS-induced colitis model via milk fat globule-EGF factor 8.
Topics: Administration, Rectal; Animals; Antigens, Surface; Butyric Acid; Cell Line; Colitis; Dextran Sulfat | 2013 |
Iron supplementation promotes gut microbiota metabolic activity but not colitis markers in human gut microbiota-associated rats.
Topics: Animals; Bacteroides; Biomarkers; Butyric Acid; Cecum; Child; Clostridium; Colitis; Colon; Dietary S | 2014 |
Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Butyric Acid; Carnitine; Colitis; Colon | 2014 |
Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Butyric Acid; Cation Transport Pro | 2015 |
Na-H Exchanger Isoform-2 (NHE2) Mediates Butyrate-dependent Na+ Absorption in Dextran Sulfate Sodium (DSS)-induced Colitis.
Topics: Animals; Butyric Acid; Colitis; Dextran Sulfate; Male; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Hy | 2015 |
Butyrate upregulates endogenous host defense peptides to enhance disease resistance in piglets via histone deacetylase inhibition.
Topics: Animals; Butyric Acid; Cell Line; Colitis; Colon; Cytokines; Defensins; Drug Evaluation, Preclinical | 2016 |
Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium.
Topics: Adult; Animals; Butyric Acid; Clostridiales; Colitis; Colon; Dextran Sulfate; Disease Models, Animal | 2016 |
Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease.
Topics: Acetic Acid; Adolescent; Anus Diseases; Butyric Acid; Case-Control Studies; Child; Colitis; Crohn Di | 2012 |
Roles of mucosal bacteria and succinic acid in colitis caused by dextran sulfate sodium in mice.
Topics: Acetates; Animals; Bacteroidaceae; Bacteroides; Butyric Acid; Carboxylic Acids; Cecum; Colitis; Coli | 2000 |
Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats.
Topics: Adenocarcinoma; Animals; Butyric Acid; Colitis; Colon; Colonic Neoplasms; Dietary Fiber; Female; Glu | 2002 |
Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes.
Topics: Amino Acid Sequence; Amino Acid Transport System ASC; Animals; Base Sequence; Butyric Acid; Carnitin | 2006 |
Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity.
Topics: Aminosalicylic Acids; Animals; Butyrates; Butyric Acid; Colitis; Factor XIII; Male; Mesalamine; Rats | 1994 |
Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model.
Topics: Animals; Butyrates; Butyric Acid; Cell Division; Colitis; Colon; Enema; Intestinal Neoplasms; Intest | 1996 |
Inhibition of butyric acid-induced colitis in mice by 16,16-dimethyl prostaglandin E2.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Butyrates; Butyric Acid; Colitis; Colon; Dose-Response Rela | 1992 |
Oxidative and synthetic functions of n-Butyrate in colonocytes.
Topics: Butyrates; Butyric Acid; Colitis; Colon; Humans | 1992 |
Short chain fatty acid-induced colitis in mice.
Topics: Administration, Rectal; Animals; Butyrates; Butyric Acid; Colitis; Edema; Male; Mice; Mice, Inbred S | 1989 |